Cannabis Technologies Commences Trading on OTCQB
June 4, 2014 (Source: Marketwired) — Cannabis Technologies Inc. (CSE:CAN)(OTCQB:CANLF) announces that as of June 04, 2014, its common stock will begin trading on OTC Markets Group’s OTCQB venture stage marketplace (“OTCQB”) under the symbol “CANLF”.
OTCQB offers investors transparent trading in early-stage and developing U.S. and international companies. To be eligible, companies must meet a minimum $0.01 bid test, be current in their reporting and undergo an annual verification and management certification process. International companies must also be listed on a qualified foreign stock exchange and receive a Letter of Introduction from a Principal American Liaison (“PAL”), which must be a qualified third-party investment bank, securities law firm or depositary bank. U.S. investors can find current financial disclosures and Real-Time Level 2 quotes for Cannabis Technologies on www.otcmarkets.com.
For further information regarding OTCQB, please visit www.otcmarkets.com.
About Cannabis Technologies (“CTI”)
CTI is a biopharmaceutical drug discovery and development company uniquely focused on the pharmacology and therapeutic potential of cannabinoids.
CTI is utilizing its proprietary “Cannabinoid Drug Design Platform” to identify new bioactive compounds within the marijuana plant that interact with certain gene responsible for specific disease.
Get our daily investorintel update
Our extensive research and intellectual properties will initially be focused on the development of several new cannabinoid based treatments for Ocular, Cancer & Angiogenesis, and Inflammation, Pain.
ON BEHALF OF THE BOARD
Craig Schneider, President and CEO
Forward Looking Statements
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
Additionally, there are known and unknown risk factors which could cause Cannabis Technologies actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein.
All forward-looking information herein is qualified in its entirety by this cautionary statement, and Cannabis Technologies disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
These risks and uncertainties include, among others, the possibility that clinical trials will not be successful, or be completed, or confirm earlier clinical trial results, risks associated with obtaining funding from third parties, risks related to the timing and costs of clinical trials and the receipt of regulatory approvals.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Raj Shah has professional experience working for over a half a dozen years at financial firms such as Merrill Lynch and First Allied Securities Inc., ... <Read more about Raj Shah>